用死后测量方法验证器官剂量不确定性的贝叶斯模型方法
Maia Avtandilashvili1, Martin Šefl2,3, Joey Y Zhou4
1United States Transuranium and Uranium Registries, College of Pharmacy and Pharmaceutical Sciences, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA, 99354, USA. m.avtandilashvili@wsu.edu.
Scientific reports
|July 2, 2025
概括
对 (Pu) 剂量估计的贝叶斯分析需要改进生物动力学模型. 当前的模型往往无法准确预测器官活动,引发了辐射保护方面的担忧.
科学领域:
- 辐射保护 辐射保护
- 生物动力学 生物动力学
- 剂量测量方法 剂量测量方法
背景情况:
- 国际辐射保护委员会模型缺乏剂量测量不确定性.
- 贝叶斯式方法提供剂量估计分布,对风险建模有价值.
- 验证贝叶斯假设需要比较预测和实际的放射性核酸活性.
研究的目的:
- 为了验证贝叶斯分析提供真实剂量信息的假设.
- 评估239Pu器官活动的生物动力学模型预测中的不确定性.
- 为了将预测的239Pu器官活动与死后测量进行比较.
主要方法:
- 利用了20名前核工人的尿液生物测试和死后组织数据.
- 采用拉丁式超立方采样来改变人类呼吸道模型的关键参数 (f_r, s_s).
- 通过最大概率的配件和预测的器官活动估计的摄入量.
主要成果:
- 预测的239Pu器官活动分布往往不包括死亡后测量的值 (75%肝脏,90%骨,50%呼吸道).
- 模型的预测并不总是保守的,可能会带来潜在的辐射保护问题.
- 显著的差异突出了对增强生物动力学模型的需求.
结论:
- 目前的生物动力学模型需要改进,以准确地反映体内的行为.
- 该研究强调了将剂量计不确定性纳入辐射保护的重要性.
- 经过验证的贝叶斯方法可以改善流行病学风险评估,如果模型得到完善.
相关概念视频
Model Approaches for Pharmacokinetic Data: Physiological Models
118
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
118
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
131
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
131
Propagation of Uncertainty from Systematic Error
894
The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this...
894
Model Approaches for Pharmacokinetic Data: Compartment Models
205
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
205
Pharmacokinetic Models: Comparison and Selection Criterion
153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
131
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
131


